Cargando…

LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models

Merosin deficient Congenital Muscular Dystrophy (MDC1A), or LAMA2-related muscular dystrophy (LAMA2-RD), is a recessive disorder resulting from mutations in the LAMA2 gene, encoding for the alpha-2 chain of laminin-211. The disease is predominantly characterized by progressive muscular dystrophy aff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Previtali, Stefano Carlo, Zambon, Alberto Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190814/ https://www.ncbi.nlm.nih.gov/pubmed/32390798 http://dx.doi.org/10.3389/fnmol.2020.00060

Ejemplares similares

Editorial: Current Insights Into LAMA2 Disease
por: Previtali, Stefano C., et al.
Publicado: (2021)

Autophagy as an Emerging Common Pathomechanism in Inherited Peripheral Neuropathies
por: Haidar, Mansour, et al.
Publicado: (2017)

Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models
por: Arreguin, Andrea J., et al.
Publicado: (2020)

LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness
por: Sarkozy, Anna, et al.
Publicado: (2020)

Nerve pathology is prevented by linker proteins in mouse models for LAMA2-related muscular dystrophy
por: Reinhard, Judith R, et al.
Publicado: (2023)

Novel pathomechanisms in inflammatory neuropathies
por: Schafflick, David, et al.
Publicado: (2017)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)

A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
por: Gawlik, Kinga I., et al.
Publicado: (2020)

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
por: Burgess, Jamie, et al.
Publicado: (2021)

Zebrafish Models of LAMA2-Related Congenital Muscular Dystrophy (MDC1A)
por: Fabian, Lacramioara, et al.
Publicado: (2020)

Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics
por: Barraza-Flores, Pamela, et al.
Publicado: (2020)

Linker Protein Repair of LAMA2 Dystrophic Neuromuscular Basement Membranes
por: Yurchenco, Peter D., et al.
Publicado: (2019)

Insights into ALS pathomechanisms: from flies to humans
por: Chai, Andrea, et al.
Publicado: (2015)

LAMA2‐related muscular dystrophy: Natural history of a large pediatric cohort
por: Zambon, Alberto A., et al.
Publicado: (2020)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
por: Singh, Dave, et al.
Publicado: (2019)

Foot Pad Skin Biopsy in Mouse Models of Hereditary Neuropathy
por: Dacci, Patrizia, et al.
Publicado: (2010)

Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology
por: Accorsi, Anthony, et al.
Publicado: (2020)

Recessive LAMA5 Variants Associated With Partial Epilepsy and Spasms in Infancy
por: Luo, Sheng, et al.
Publicado: (2022)

Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments
por: Krenn, Martin, et al.
Publicado: (2020)

Animal Models as a Tool to Design Therapeutical Strategies for CMT-like Hereditary Neuropathies
por: Bosco, Luca, et al.
Publicado: (2021)

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
por: Fang, Tingyu, et al.
Publicado: (2022)

Dalai Lama
Publicado: (2020)

Dalaï-Lama
Publicado: (2020)

Lamas in loops
por: Lai, Eric C.
Publicado: (2003)

A systematic literature review on the role of glial cells in the pathomechanisms of migraine
por: Zhang, Shanshan, et al.
Publicado: (2023)

CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in Merosin-deficient congenital muscular dystrophy
por: Arockiaraj, Annie I., et al.
Publicado: (2023)

Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions
por: Emtenani, Shirin, et al.
Publicado: (2023)

LAMA: automated image analysis for the developmental phenotyping of mouse embryos
por: Horner, Neil R., et al.
Publicado: (2021)

Dalai Lama at CERN
Publicado: (1983)

Visit of Dalay Lama
Publicado: (1983)

Altered sensorimotor processing in irritable bowel syndrome: Evidence for a transdiagnostic pathomechanism in functional somatic disorders
por: Schröder, Lena, et al.
Publicado: (2022)

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
por: Moreira Soares Oliveira, Bernardo, et al.
Publicado: (2017)

Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy
por: Oliveira-Santos, Ariany, et al.
Publicado: (2023)

Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy
por: Starobova, H., et al.
Publicado: (2019)

Inclusion body myositis – pathomechanism and lessons from genetics
por: Murnyák, Balázs, et al.
Publicado: (2015)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
por: Barraza-Flores, Pamela, et al.
Publicado: (2020)

Dalai Lama comes to CERN
Publicado: (1983)

A Conversation with the Grand Lama
Publicado: (1889)

Delirium-Onset of Prodromal Dementia With Lewy Bodies—Putative Brainstem-Related Pathomechanism and Clinical Relevance
por: Hansen, Niels, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0uqev1kr1nojjkse75k4hta6p6